KRAS and neoplasm: Interestingly, in one these patients the driver mutation in the tumor was identified to be in PTPN11, in the same gene that frequently acquires somatic mutations leading to HS in BMDs [16,17]; and in two other FA patients, mutations in the tumors were in KRAS, also identified in HS of BMDs [17].